May 9, 2024, 00:16
Update CheckMate 9ER summarized by Sergio Cifuentes
Sergio Cifuentes, Cancer Research Project Manager at
“Update CheckMate 9ER
– PFS: 16.6 m vs 8.4 m
– OS: 49.5 m vs 35.5 m (HR 0.70; 95% CI 0.56-0.87)
– CR: 13% vs 5%
– ORR: 56% (50-62%) vs 28% (23-33%)
– mDoR: 22.1 m vs 16.1 m
Benefit in intermediate/poor
Mexican Participation 35%”
Proceed to the article.
Source: Sergio Cifuentes/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 19, 2024, 10:18
Nov 19, 2024, 10:05
Nov 19, 2024, 09:53
Nov 19, 2024, 09:44
Nov 19, 2024, 09:40
Nov 19, 2024, 09:28